A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Tvardi Therapeutics, Incorporated
Tvardi Therapeutics, Incorporated
Mayo Clinic
Roswell Park Cancer Institute
Twinpig Biolab, Inc.
Eisai Inc.
TriSalus Life Sciences, Inc.
BioInvent International AB
Medivir
Imperial College London
GI Innovation, Inc.
Salubris Biotherapeutics Inc
Amgen
Incyte Corporation
Incyte Corporation
Eli Lilly and Company